Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$2.41 - $3.88 $27,346 - $44,026
-11,347 Reduced 19.29%
47,483 $117,000
Q3 2023

Nov 08, 2023

SELL
$1.66 - $3.83 $237,756 - $548,559
-143,227 Reduced 70.88%
58,830 $159,000
Q2 2023

Aug 03, 2023

SELL
$1.8 - $3.98 $114,978 - $254,230
-63,877 Reduced 24.02%
202,057 $577,000
Q4 2022

Feb 09, 2023

BUY
$3.23 - $5.64 $600,566 - $1.05 Million
185,934 Added 232.42%
265,934 $1.42 Million
Q4 2022

Feb 08, 2023

SELL
$3.23 - $5.64 $600,566 - $1.05 Million
-185,934 Reduced 69.92%
80,000 $5.69 Million
Q4 2021

Feb 14, 2022

BUY
$17.49 - $26.72 $1.28 Million - $1.96 Million
73,190 Added 37.97%
265,934 $5.48 Million
Q3 2021

Nov 10, 2021

BUY
$17.47 - $27.49 $1.62 Million - $2.55 Million
92,744 Added 92.74%
192,744 $4.72 Million
Q2 2021

Aug 05, 2021

BUY
$23.73 - $27.98 $2.37 Million - $2.8 Million
100,000 New
100,000 $2.44 Million

Others Institutions Holding TKNO

About Alpha Teknova, Inc.


  • Ticker TKNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 28,080,500
  • Market Cap $241M
  • Description
  • Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...
More about TKNO
Track This Portfolio

Track Premier Fund Managers LTD Portfolio

Follow Premier Fund Managers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Premier Fund Managers LTD with notifications on news.